224 related articles for article (PubMed ID: 15635025)
21. Re: A VIM-1-metallo-beta-lactamase-producing Klebsiella pneumoniae clinical isolate in an acute hospital in Germany.
Shah PM
Int J Antimicrob Agents; 2009 Oct; 34(4):381. PubMed ID: 19502012
[No Abstract] [Full Text] [Related]
22. Combined disc methods for the detection of KPC- and/or VIM-positive Klebsiella pneumoniae: improving reliability for the double carbapenemase producers.
Miriagou V; Tzelepi E; Kotsakis SD; Daikos GL; Bou Casals J; Tzouvelekis LS
Clin Microbiol Infect; 2013 Sep; 19(9):E412-5. PubMed ID: 23627340
[TBL] [Abstract][Full Text] [Related]
23. In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase.
Elliott E; Brink AJ; van Greune J; Els Z; Woodford N; Turton J; Warner M; Livermore DM
Clin Infect Dis; 2006 Jun; 42(11):e95-8. PubMed ID: 16652304
[TBL] [Abstract][Full Text] [Related]
24. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey.
Psichogiou M; Tassios PT; Avlamis A; Stefanou I; Kosmidis C; Platsouka E; Paniara O; Xanthaki A; Toutouza M; Daikos GL; Tzouvelekis LS
J Antimicrob Chemother; 2008 Jan; 61(1):59-63. PubMed ID: 17999975
[TBL] [Abstract][Full Text] [Related]
25. False susceptibility to cefotetan reported by MicroScan for DHA-type AmpC beta-lactamase-producing Klebsiella pneumoniae.
Lee SY; Park YJ; Oh EJ; Yoo JK; Park JJ; Park KG; Han K
Clin Microbiol Infect; 2007 May; 13(5):539-41. PubMed ID: 17331122
[TBL] [Abstract][Full Text] [Related]
26. Comparison of polymyxin B, tigecycline, cefepime, and meropenem MICs for KPC-producing Klebsiella pneumoniae by broth microdilution, Vitek 2, and Etest.
Lat A; Clock SA; Wu F; Whittier S; Della-Latta P; Fauntleroy K; Jenkins SG; Saiman L; Kubin CJ
J Clin Microbiol; 2011 May; 49(5):1795-8. PubMed ID: 21367993
[TBL] [Abstract][Full Text] [Related]
27. Comparison of meropenem MICs and susceptibilities for carbapenemase-producing Klebsiella pneumoniae isolates by various testing methods.
Bulik CC; Fauntleroy KA; Jenkins SG; Abuali M; LaBombardi VJ; Nicolau DP; Kuti JL
J Clin Microbiol; 2010 Jul; 48(7):2402-6. PubMed ID: 20484603
[TBL] [Abstract][Full Text] [Related]
28. Meropenem resistance in imipenem-susceptible meropenem-resistant Klebsiella pneumoniae isolates not detected by rapid automated testing systems.
Harino T; Kayama S; Kuwahara R; Kashiyama S; Shigemoto N; Onodera M; Yokozaki M; Ohge H; Sugai M
J Clin Microbiol; 2013 Aug; 51(8):2735-8. PubMed ID: 23720796
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial activity evaluation and comparison of methods of susceptibility for Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacter spp. isolates.
Rechenchoski DZ; Dambrozio AML; Vivan ACP; Schuroff PA; Burgos TDN; Pelisson M; Perugini MRE; Vespero EC
Braz J Microbiol; 2017; 48(3):509-514. PubMed ID: 28552659
[TBL] [Abstract][Full Text] [Related]
30. In vitro activity of fosfomycin in combination with imipenem, meropenem, colistin and tigecycline against OXA 48-positive Klebsiella pneumoniae strains.
Evren E; Azap OK; Çolakoğlu Ş; Arslan H
Diagn Microbiol Infect Dis; 2013 Jul; 76(3):335-8. PubMed ID: 23726147
[TBL] [Abstract][Full Text] [Related]
31. Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 beta-lactamases co-mediated by porin loss.
Lee K; Yong D; Choi YS; Yum JH; Kim JM; Woodford N; Livermore DM; Chong Y
Int J Antimicrob Agents; 2007 Feb; 29(2):201-6. PubMed ID: 17204406
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Cha R
Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of polymyxin susceptibility profile among KPC-producing Klebsiella pneumoniae using Etest and MicroScan WalkAway automated system.
Perez LR
APMIS; 2015 Nov; 123(11):951-4. PubMed ID: 26361367
[TBL] [Abstract][Full Text] [Related]
34. Antibiotic-resistance patterns and frequency of extended-spectrum beta-lactamase-producing isolates of Klebsiella pneumoniae in Tehran.
Feizabadi MM; Etemadi G; Yadegarinia D; Rahmati M; Shabanpoor S; Bokaei S
Med Sci Monit; 2006 Nov; 12(11):BR362-5. PubMed ID: 17072265
[TBL] [Abstract][Full Text] [Related]
35. Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Bishara J; Livne G; Ashkenazi S; Levy I; Pitlik S; Ofir O; Lev B; Samra Z
Isr Med Assoc J; 2005 May; 7(5):298-301. PubMed ID: 15909461
[TBL] [Abstract][Full Text] [Related]
36. Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agents.
Sader HS; Fritsche TR; Jones RN
J Clin Microbiol; 2006 Mar; 44(3):1101-4. PubMed ID: 16517904
[TBL] [Abstract][Full Text] [Related]
37. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
Tofteland S; Haldorsen B; Dahl KH; Simonsen GS; Steinbakk M; Walsh TR; Sundsfjord A;
J Clin Microbiol; 2007 Jan; 45(1):199-205. PubMed ID: 17079502
[TBL] [Abstract][Full Text] [Related]
38. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss.
Gülmez D; Woodford N; Palepou MF; Mushtaq S; Metan G; Yakupogullari Y; Kocagoz S; Uzun O; Hascelik G; Livermore DM
Int J Antimicrob Agents; 2008 Jun; 31(6):523-6. PubMed ID: 18339523
[TBL] [Abstract][Full Text] [Related]
39. Sepsis in neonates due to imipenem-resistant Klebsiella pneumoniae producing NDM-1 in India.
Roy S; Viswanathan R; Singh AK; Das P; Basu S
J Antimicrob Chemother; 2011 Jun; 66(6):1411-3. PubMed ID: 21393155
[No Abstract] [Full Text] [Related]
40. First description of CTX-M-15-producing Klebsiella pneumoniae in Portugal.
Conceição T; Brízio A; Duarte A; Lito LM; Cristino JM; Salgado MJ
Antimicrob Agents Chemother; 2005 Jan; 49(1):477-8. PubMed ID: 15616344
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
